Contemporary OBGyn

CONTINUE TO SITE >

OR WAIT 15 SECS

Why a Women's Health Company?BV & Sexually Transmitted InfectionsCervical Cancer ScreeningCervical Cancer TodayCervical RipeningEndometriosisLaser Treatment for GSMOBGYNs discuss ORILISSA® (elagolix)OsteoporosisSurgeryTB Screening

ContraceptionCOVID-19GynecologyLegally SpeakingLife TransitionsObstetricsVulvovaginalWell Woman

All NewsResidents CornerPractice Management

Medical World NewsQuizzes

Podcasts Videos

Conference CoverageConference Listing

Digital EditionDigital Supplements

CMEJob BoardSponsored Resources

eNewsletterPrint Subscription

Advertise
Contact Us
Job Board
Editorial
Terms of Use
Privacy Policy
Do Not Sell My Personal Information

© 2020 MJH Life Sciences and Contemporary OB/GYN. All rights reserved.

Spotlight

Why a Women's Health Company?
BV & Sexually Transmitted Infections
Cervical Cancer Screening
Cervical Cancer Today
Cervical Ripening
Endometriosis
Laser Treatment for GSM
OBGYNs discuss ORILISSA® (elagolix)
Osteoporosis
Surgery
TB Screening

ClinicalSee All >

Contraception
COVID-19
Gynecology
Legally Speaking
Life Transitions
Obstetrics
Vulvovaginal
Well Woman

Advertise
Contact Us
Job Board
Editorial
Terms of Use
Privacy Policy
Do Not Sell My Personal Information

© 2020 MJH Life Sciences^™ and Contemporary OB/GYN. All rights reserved.

Should we consider treating patients with refractory PCOS for infertility

March 1, 2000

No. Safety and cost-effectiveness concerns overshadow the potential benefits